Author:
Mocan Lucian,Mosteanu Ofelia,Pop Teodora,Agoston-Coldea Lucia,Iancu Cornel,Mocan Teodora,Luminita Furcea
Reference66 articles.
1. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer. 1996;78(8):1820-1828
2. PDQ Screening and Prevention Editorial Board. In: Anonymous, editor. Esophageal Cancer Screening (PDQ(R)): Health Professional Version. In PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute; 2002
3. Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: Experiences at a single institution in Japan. Annals of Surgical Oncology. 2012;19(2):677-683
4. Spechler SJ. Barrett esophagus and risk of esophageal cancer: A clinical review. JAMA. 2013;310(6):627-636
5. Duits LC, Phoa KN, Curvers WL, Ten Kate FJ, Meijer GA, Seldenrijk CA, Offerhaus GJ, Visser M, Meijer SL, Krishnadath KK, Tijssen JG, Mallant-Hent RC, Bergman JJ. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Gut. 2015;64(5):700-706